[1] [1] JIANG X, LIU H, CHRN X, et al. Structure of follicle-stimulating hormone in complex with the entire ectodomain of its receptor［J］. Proceedings of the National Academy of Sciences of the United States of America, 2012, 109(31): 12491-12496.

[2] [2] AITTOMAKI K, LUCENA J L, PAKARINEN P, et al. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure［J］. Cell, 1995, 82(6): 959-968.

[3] [3] KHOR S, LYU Q, KUANG Y, et al. Novel FSHR variants causing female resistant ovary syndrome［J］. Molecular Genetics & Genomic Medicine, 2020, 8(2): e1082.

[4] [4] FLAGEOLE C, TOUFAILY C, BERNARD D J, et al. Successful in vitro maturation of oocytes in a woman with gonadotropin-resistant ovary syndrome associated with a novel combination of FSH receptor gene variants: a case report［J］. Journal of Assisted Reproduction and Genetics, 2019, 36(3): 425-432.

[5] [5] BRAMBLE M S, GOLDSTEIN E H, LIPSON A, et al. A novel follicle-stimulating hormone receptor mutation causing primary ovarian failure: a fertility application of whole exome sequencing［J］. Human Reproduction (Oxford, England), 2016, 31(4): 905-914.

[7] [7] QIN Y, JIAO X, SIMPSON J L, et al. Genetics of primary ovarian insufficiency: new developments and opportunities［J］. Human Reproduction Update, 2015, 21(6): 787-808.

[8] [8] HALLER-KIKKATALO K, SALUMETS A, UIBO R. Review on autoimmune reactions in female infertility: antibodies to follicle stimulating hormone［J］. Clinical & Developmental Immunology, 2012, 2012: 762541.

[9] [9] JONES G S, DE MORAES-RUEHSEN M. A new syndrome of amenorrhae in association with hypergonadotropism and apparently normal ovarian follicular apparatus［J］. American Journal of Obstetrics and Gynecology, 1969, 104(4): 597-600.

[10] [10] ROGENHOFER N, PAVLIK R, JESCHKE U, et al. Effective ovarian stimulation in a patient with resistant ovary syndrome and antigonadotrophin antibodies［J］. American Journal of Reproductive Immunology, 2015, 73(2): 185-191.

[11] [11] TAPANAINEN J S, AITTOMAKI K, MIN J, et al. Men homozygous for an inactivating mutation of the follicle-stimulating hormone (FSH) receptor gene present variable suppression of spermatogenesis and fertility［J］. Nature Genetics, 1997, 15(2): 205-206.

[13] [13] MCLAREN W, PRITCHARD B, RIOS D, et al. Deriving the consequences of genomic variants with the Ensembl API and SNP effect predictor［J］. Bioinformatics (Oxford, England), 2010, 26(16): 2069-2070.

[14] [14] NG P C, HENIKOFF S. Predicting deleterious amino acid substitutions［J］. Genome Research, 2001, 11(5): 863-874.

[15] [15] RAMENSKY V, BORK P, SUNYAEV S. Human non-synonymous SNPs: server and survey［J］. Nucleic Acids Research, 2002, 30(17): 3894-3900.

[16] [16] ADZHUBEI I A, SCHMIDT S, PESHKIN L, et al. A method and server for predicting damaging missense mutations［J］. Nature Methods, 2010, 7(4): 248-249.

[17] [17] RICHARDS S, AZIZ N, BALE S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology［J］. Genetics in Medicine: Official Journal of the American College of Medical Genetics, 2015, 17(5): 405-424.

[18] [18] DEN DUNNEN J T, DALGLEISH R, MAGLOTT D R, et al. HGVS recommendations for the description of sequence variants: 2016 Uupdate［J］. Human Mutation, 2016, 37(6): 564-569.

[19] [19] EDGAR R C. MUSCLE: multiple sequence alignment with high accuracy and high throughput［J］. Nucleic Acids Research, 2004, 32(5): 1792-1797.

[20] [20] MEDURI G, TOURAINE P, BEAU I, et al. Delayed puberty and primary amenorrhea associated with a novel mutation of the human follicle-stimulating hormone receptor: clinical, histological, and molecular studies［J］. The Journal of Clinical Endocrinology and Metabolism, 2003, 88(8): 3491-3498.